|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$63.48 0.00 (0.00%) as of 4:30 Mon 12/16
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
207,851,000 |
| Market
Cap: |
13.19(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$53.58 - $63.48 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 986 |
| Guru Rank Value : 0.4 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$49,980 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
2,800 |
26,398 |
37,461 |
| Total Sell Value |
$0 |
$167,160 |
$1,550,163 |
$2,062,744 |
| Total People Sold |
0 |
1 |
9 |
17 |
| Total Sell Transactions |
0 |
1 |
14 |
39 |
| End Date |
2025-02-02 |
2024-11-01 |
2024-05-03 |
2023-05-04 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Maselli Alessandro |
President & CEO |
• • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(290,745) |
0 |
|
- |
|
| Maselli Alessandro |
President & CEO |
• • – |
2024-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
113,224 |
113,224 |
|
- |
|
| Greisch John J |
Executive Chair |
• • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(113,462) |
0 |
|
- |
|
| Greisch John J |
Executive Chair |
• • – |
2024-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
33,530 |
33,530 |
|
- |
|
| Greisch John J |
Executive Chair |
• • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(34,000) |
0 |
|
- |
|
| Barg Steven |
|
– • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,374) |
0 |
|
- |
|
| Classon Rolf A |
|
– • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(47,984) |
0 |
|
- |
|
| Evoli Lisa |
SVP, Chief HR Officer |
• – – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(51,398) |
0 |
|
- |
|
| Evoli Lisa |
SVP, Chief HR Officer |
• – – |
2024-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
12,032 |
12,032 |
|
- |
|
| Gunther Scott |
SVP, Quality & Reg. Affairs |
• – – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(52,573) |
0 |
|
- |
|
| Gunther Scott |
SVP, Quality & Reg. Affairs |
• – – |
2024-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
12,938 |
12,938 |
|
- |
|
| Hopson Ricky |
Pres. BioProduct Delivery, CoS |
• – – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,696) |
0 |
|
- |
|
| Hopson Ricky |
Pres. BioProduct Delivery, CoS |
• – – |
2024-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,722 |
10,722 |
|
- |
|
| Lucier Gregory T |
|
– • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(36,914) |
0 |
|
- |
|
| Stahl Jack L |
|
– • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(47,984) |
0 |
|
- |
|
| Carroll J Martin |
|
– • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(32,734) |
0 |
|
- |
|
| Barber Michael J |
|
– • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,052) |
0 |
|
- |
|
| Gennadios Aristippos |
Group Pres. Pharma & Consumer |
• – – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(135,286) |
0 |
|
- |
|
| Gennadios Aristippos |
Group Pres. Pharma & Consumer |
• – – |
2024-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
21,562 |
21,562 |
|
- |
|
| Okey Stephanie |
|
– • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,635) |
0 |
|
- |
|
| Ferraro Joseph Anthony |
SVP, General Counsel, CCO |
• – – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,232) |
0 |
|
- |
|
| Ferraro Joseph Anthony |
SVP, General Counsel, CCO |
• – – |
2024-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
14,265 |
14,265 |
|
- |
|
| Ryan Michelle R |
|
– • – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,835) |
0 |
|
- |
|
| Masanovich Matti |
SVP, Chief Financial Officer |
• – – |
2024-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(148,166) |
0 |
|
- |
|
| Masanovich Matti |
SVP, Chief Financial Officer |
• – – |
2024-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
71,691 |
71,691 |
|
- |
|
828 Records found
|
|
Page 1 of 34 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
